Progyny (PGNY) Competitors $21.34 -0.06 (-0.30%) As of 03:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PGNY vs. HIMS, GH, OPCH, RDNT, PIII, SHC, BTSG, PRVA, WGS, and SGRYShould you be buying Progyny stock or one of its competitors? The main competitors of Progyny include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), P3 Health Partners (PIII), Sotera Health (SHC), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), GeneDx (WGS), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. Progyny vs. Hims & Hers Health Guardant Health Option Care Health RadNet P3 Health Partners Sotera Health BrightSpring Health Services Privia Health Group GeneDx Surgery Partners Progyny (NASDAQ:PGNY) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, community ranking, dividends, earnings and risk. Does the MarketBeat Community believe in PGNY or HIMS? Progyny received 59 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 70.83% of users gave Progyny an outperform vote while only 36.44% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformProgynyOutperform Votes10270.83% Underperform Votes4229.17% Hims & Hers HealthOutperform Votes4336.44% Underperform Votes7563.56% Do analysts rate PGNY or HIMS? Progyny currently has a consensus target price of $23.64, indicating a potential upside of 10.78%. Hims & Hers Health has a consensus target price of $38.25, indicating a potential upside of 41.83%. Given Hims & Hers Health's higher possible upside, analysts plainly believe Hims & Hers Health is more favorable than Progyny.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Progyny 0 Sell rating(s) 8 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.38Hims & Hers Health 2 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.21 Do institutionals and insiders hold more shares of PGNY or HIMS? 94.9% of Progyny shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 12.3% of Progyny shares are held by insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more volatility and risk, PGNY or HIMS? Progyny has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. Does the media prefer PGNY or HIMS? In the previous week, Hims & Hers Health had 9 more articles in the media than Progyny. MarketBeat recorded 20 mentions for Hims & Hers Health and 11 mentions for Progyny. Progyny's average media sentiment score of 1.32 beat Hims & Hers Health's score of 0.62 indicating that Progyny is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Progyny 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 10 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, PGNY or HIMS? Progyny has higher earnings, but lower revenue than Hims & Hers Health. Progyny is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProgyny$1.17B1.56$62.04M$0.5737.43Hims & Hers Health$1.48B4.06-$23.55M$0.5449.94 Is PGNY or HIMS more profitable? Hims & Hers Health has a net margin of 8.19% compared to Progyny's net margin of 5.03%. Progyny's return on equity of 11.36% beat Hims & Hers Health's return on equity.Company Net Margins Return on Equity Return on Assets Progyny5.03% 11.36% 7.87% Hims & Hers Health 8.19%10.97%8.29% SummaryHims & Hers Health beats Progyny on 9 of the 17 factors compared between the two stocks. Remove Ads Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PGNY vs. The Competition Export to ExcelMetricProgynyhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.82B$1.89B$5.30B$7.37BDividend YieldN/A7.10%5.11%4.31%P/E Ratio36.8114.6821.7117.79Price / Sales1.564.14378.3096.40Price / Cash35.589.3238.1534.64Price / Book3.703.956.433.98Net Income$62.04M$87.49M$3.20B$247.33M7 Day Performance-4.15%-5.36%4.86%4.34%1 Month Performance2.04%-13.05%-9.80%-7.83%1 Year Performance-34.85%-32.52%10.77%1.29% Progyny Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PGNYProgyny2.3642 of 5 stars$21.34-0.3%$23.64+10.8%-35.9%$1.82B$1.17B36.81310Short Interest ↓News CoveragePositive NewsHIMSHims & Hers Health3.5684 of 5 stars$28.21+3.6%$38.25+35.6%+112.1%$6.27B$1.48B64.12650Insider TradeGap DownGHGuardant Health4.1717 of 5 stars$45.16+3.3%$49.00+8.5%+179.6%$5.57B$739.02M-12.691,790OPCHOption Care Health3.1393 of 5 stars$31.84+0.9%$33.00+3.6%+3.0%$5.23B$5.00B26.765,600Short Interest ↑Positive NewsHigh Trading VolumeRDNTRadNet3.8227 of 5 stars$53.36-0.1%$69.75+30.7%+5.5%$3.95B$1.83B-762.188,970News CoveragePositive NewsPIIIP3 Health Partners1.7906 of 5 stars$8.99+18.6%$0.25-97.2%-58.4%$3.23B$1.50B-10.70500News CoverageHigh Trading VolumeSHCSotera Health2.4128 of 5 stars$10.62+1.0%$15.20+43.1%-3.7%$3.01B$1.10B42.483,000BTSGBrightSpring Health Services2.9005 of 5 stars$17.10+0.1%$21.67+26.7%+59.0%$2.99B$11.27B-65.7735,000News CoveragePositive NewsPRVAPrivia Health Group3.765 of 5 stars$24.05-0.2%$26.87+11.7%+34.9%$2.92B$1.74B240.52810Analyst ForecastWGSGeneDx1.9637 of 5 stars$101.04+4.6%$72.33-28.4%+922.7%$2.84B$305.45M-51.551,200Positive NewsGap DownSGRYSurgery Partners2.7513 of 5 stars$21.32+1.6%$36.63+71.8%-14.6%$2.72B$3.11B-44.4213,500Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies Hims & Hers Health Alternatives Guardant Health Alternatives Option Care Health Alternatives RadNet Alternatives P3 Health Partners Alternatives Sotera Health Alternatives BrightSpring Health Services Alternatives Privia Health Group Alternatives GeneDx Alternatives Surgery Partners Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PGNY) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PGNY Stock Free PGNY Stock Alerts